Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hilary Smith Connery, M.D., Ph.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Rockett IRH, Caine ED, Connery HS, Nolte KB. Overcoming the limitations of 'accident' as a manner of death for drug overdose mortality: case for a death certificate checkbox. Inj Prev. 2020 Sep 11. PMID: 32917742.
    Citations:    
  2. Rosenthal RN, Welsh JW, Connery HS, Barnett BS, DeVido J, Hill K, Levin FR, Williams AR, Greenfield SF. Advocacy and Public Policy Efforts of the American Academy of Addiction Psychiatry. Am J Addict. 2020 Sep; 29(5):401-406. PMID: 32902042.
    Citations:    
  3. Connery HS, McHugh RK, Reilly M, Shin S, Greenfield SF. Substance Use Disorders in Global Mental Health Delivery: Epidemiology, Treatment Gap, and Implementation of Evidence-Based Treatments. Harv Rev Psychiatry. 2020 Sep/Oct; 28(5):316-327. PMID: 32925514.
    Citations:    
  4. Williams AR, Hill KP, Rosenthal RN, Connery HS, Welsh JW. Commentary: Proposed Model State Cannabis Laws to Reduce Harms. Am J Addict. 2020 Sep; 29(5):426-427. PMID: 32902047.
    Citations:    
  5. Connery HS, Weiss RD. Discontinuing Buprenorphine Treatment of Opioid Use Disorder: What Do We (Not) Know? Am J Psychiatry. 2020 02 01; 177(2):104-106. PMID: 32008394.
    Citations:    
  6. Connery HS, Taghian N, Kim J, Griffin M, Rockett IRH, Weiss RD, Kathryn McHugh R. Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder. Drug Alcohol Depend. 2019 12 01; 205:107612. PMID: 31627077.
    Citations:    
  7. Rockett IRH, Caine ED, Connery HS, Nolte KB, Nestadt PS, Nelson LS, Jia H. Unrecognised self-injury mortality (SIM) trends among racial/ethnic minorities and women in the USA. Inj Prev. 2020 Oct; 26(5):439-447. PMID: 31551367.
    Citations:    
  8. Madras BK, Connery H. Psychiatry and the Opioid Overdose Crisis. Focus (Am Psychiatr Publ). 2019 Apr; 17(2):128-133. PMID: 31975968.
    Citations:    
  9. Schwartz MKD, Connery H. Cannabis legislation and substance use disorder treatment. Am J Addict. 2019 02; 28(2):127-129. PMID: 30829436.
    Citations:    
  10. Connery HS, Weiss RD. Microscopes and Telescopes: the Societal Impact of Substance Use Disorder Treatment. Am J Psychiatry. 2018 10 01; 175(10):925-926. PMID: 30269546.
    Citations:    Fields:    
  11. Rockett IRH, Caine ED, Connery HS, Greenfield SF. Mortality in the United States from self-injury surpasses diabetes: a prevention imperative. Inj Prev. 2019 08; 25(4):331-333. PMID: 30150252.
    Citations:    Fields:    
  12. Rockett IRH, Connery HS. Variation in Deaths From Intentional Injury and Substance Use. JAMA. 2018 08 14; 320(6):601. PMID: 30120467.
    Citations:    Fields:    Translation:Humans
  13. Rockett IRH, Caine ED, Stack S, Connery HS, Nolte KB, Lilly CL, Miller TR, Nelson LS, Putnam SL, Nestadt PS, Jia H. Method overtness, forensic autopsy, and the evidentiary suicide note: A multilevel National Violent Death Reporting System analysis. PLoS One. 2018; 13(5):e0197805. PMID: 29787584.
    Citations:    Fields:    Translation:Humans
  14. Rockett IRH, Caine ED, Connery HS, D'Onofrio G, Gunnell DJ, Miller TR, Nolte KB, Kaplan MS, Kapusta ND, Lilly CL, Nelson LS, Putnam SL, Stack S, Värnik P, Webster LR, Jia H. Discerning suicide in drug intoxication deaths: Paucity and primacy of suicide notes and psychiatric history. PLoS One. 2018; 13(1):e0190200. PMID: 29320540.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  15. Barnett B, Connery HS. Implementation challenges of the final rule of Title 42 of the Code of Federal Regulations part 2: can privacy endure in an era of electronic health information exchange? Am J Addict. 2018 Jan; 27(1):37-38. PMID: 29283482.
    Citations:    Fields:    
  16. Medlock MM, Rosmarin DH, Connery HS, Griffin ML, Weiss RD, Karakula SL, McHugh RK. Religious coping in patients with severe substance use disorders receiving acute inpatient detoxification. Am J Addict. 2017 Oct; 26(7):744-750. PMID: 28836712.
    Citations:    Fields:    Translation:Humans
  17. McHugh RK, Votaw VR, Fulciniti F, Connery HS, Griffin ML, Monti PM, Weiss RD. Perceived barriers to smoking cessation among adults with substance use disorders. J Subst Abuse Treat. 2017 03; 74:48-53. PMID: 28132700.
    Citations: 1     Fields:    Translation:Humans
  18. Votaw VR, Wittenauer J, Connery HS, Weiss RD, McHugh RK. Perceived risk of heroin use among nonmedical prescription opioid users. Addict Behav. 2017 02; 65:218-223. PMID: 27544695.
    Citations: 3     Fields:    Translation:Humans
  19. Marcovitz DE, McHugh RK, Volpe J, Votaw V, Connery HS. Predictors of early dropout in outpatient buprenorphine/naloxone treatment. Am J Addict. 2016 09; 25(6):472-7. PMID: 27442456.
    Citations: 5     Fields:    Translation:Humans
  20. Miller AC, Nelson AK, Livchits V, Greenfield SF, Yanova G, Yanov S, Connery HS, Atwood S, Lastimoso CS, Shin SS. Understanding HIV Risk Behavior among Tuberculosis Patients with Alcohol Use Disorders in Tomsk, Russian Federation. PLoS One. 2016; 11(2):e0148910. PMID: 26871943.
    Citations: 1     Fields:    Translation:Humans
  21. DeVido J, Connery H, Hill KP. Sleep-disordered breathing in patients with opioid use disorders in long-term maintenance on buprenorphine-naloxone: A case series. J Opioid Manag. 2015 Jul-Aug; 11(4):363-6. PMID: 26312963.
    Citations: 2     Fields:    Translation:Humans
  22. Suzuki J, Ellison TV, Connery HS, Surber C, Renner JA. Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs. Acad Psychiatry. 2016 Jun; 40(3):498-502. PMID: 26017618.
    Citations:    Fields:    Translation:Humans
  23. Connery HS. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harv Rev Psychiatry. 2015 Mar-Apr; 23(2):63-75. PMID: 25747920.
    Citations: 28     Fields:    Translation:Humans
  24. McDermott KA, Griffin ML, Connery HS, Hilario EY, Fiellin DA, Fitzmaurice GM, Weiss RD. Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. J Clin Psychiatry. 2015 Feb; 76(2):189-94. PMID: 25562462.
    Citations: 4     Fields:    Translation:Humans
  25. Suzuki J, Connery HS, Ellison TV, Renner JA. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency. Am J Addict. 2014 Nov-Dec; 23(6):618-22. PMID: 25065457.
    Citations: 2     Fields:    Translation:Humans
  26. Hilario EY, Griffin ML, McHugh RK, McDermott KA, Connery HS, Fitzmaurice GM, Weiss RD. Denial of urinalysis-confirmed opioid use in prescription opioid dependence. J Subst Abuse Treat. 2015 Jan; 48(1):85-90. PMID: 25115135.
    Citations: 3     Fields:    Translation:Humans
  27. Greenfield SF, Sugarman DE, Freid CM, Bailey GL, Crisafulli MA, Kaufman JS, Wigderson S, Connery HS, Rodolico J, Morgan-Lopez AA, Fitzmaurice GM. Group therapy for women with substance use disorders: results from the Women's Recovery Group Study. Drug Alcohol Depend. 2014 Sep 01; 142:245-53. PMID: 25042759.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  28. Chartoff EH, Connery HS. It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system. Front Pharmacol. 2014; 5:116. PMID: 24904419.
    Citations: 22     
  29. Greenfield SF, Crisafulli MA, Kaufman JS, Freid CM, Bailey GL, Connery HS, Rapoza M, Rodolico J. Implementing substance abuse group therapy clinical trials in real-world settings: challenges and strategies for participant recruitment and therapist training in the Women's Recovery Group Study. Am J Addict. 2014 May-Jun; 23(3):197-204. PMID: 24724875.
    Citations: 3     Fields:    Translation:Humans
  30. Weiss RD, Griffin ML, Potter JS, Dodd DR, Dreifuss JA, Connery HS, Carroll KM. Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management? Drug Alcohol Depend. 2014 Jul 01; 140:118-22. PMID: 24831754.
    Citations: 5     Fields:    Translation:Humans
  31. Connery HS, Albright BB, Rodolico JM. Adolescent substance use and unplanned pregnancy: strategies for risk reduction. Obstet Gynecol Clin North Am. 2014 Jun; 41(2):191-203. PMID: 24845484.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  32. Connery HS, Rayburn WF. Substance abuse during pregnancy. Obstet Gynecol Clin North Am. 2014 Jun; 41(2):xiii-xiv. PMID: 24845495.
    Citations:    Fields:    Translation:HumansPHPublic Health
  33. Connery H, Greenfield S, Livchits V, McGrady L, Patrick N, Lastimoso CS, Heney JH, Nelson AK, Shields A, Stepanova YP, Petrova LY, Anastasov OV, Novoseltseva OI, Shin SS. Training and fidelity monitoring of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia: the IMPACT Effectiveness Trial. Subst Use Misuse. 2013 Jun; 48(9):784-92. PMID: 23750742.
    Citations:    Fields:    Translation:Humans
  34. Shin S, Livchits V, Connery HS, Shields A, Yanov S, Yanova G, Fitzmaurice GM, Nelson AK, Greenfield SF. Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia. Addiction. 2013 Aug; 108(8):1387-96. PMID: 23490304.
    Citations: 8     Fields:    Translation:Humans
  35. Schuman-Olivier Z, Connery H, Griffin ML, Wyatt SA, Wartenberg AA, Borodovsky J, Renner JA, Weiss RD. Clinician beliefs and attitudes about buprenorphine/naloxone diversion. Am J Addict. 2013 Nov-Dec; 22(6):574-80. PMID: 24131165.
    Citations: 5     Fields:    Translation:Humans
  36. Hill KP, Bennett HE, Griffin ML, Connery HS, Fitzmaurice GM, Subramaniam G, Woody GE, Weiss RD. Association of cannabis use with opioid outcomes among opioid-dependent youth. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):342-5. PMID: 23528523.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  37. McHugh RK, Devito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, Connery HS, Weiss RD. Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013 Jul; 45(1):38-43. PMID: 23313145.
    Citations: 23     Fields:    Translation:Humans
  38. Hill KP, Rice LS, Connery HS, Weiss RD. Diagnosing and treating opioid dependence. J Fam Pract. 2012 Oct; 61(10):588-97. PMID: 23106060.
    Citations:    Fields:    Translation:Humans
  39. Shin SS, Livchits V, Nelson AK, Lastimoso CS, Yanova GV, Yanov SA, Mishustin SP, Connery HS, Greenfield SF. Implementing evidence-based alcohol interventions in a resource-limited setting: novel delivery strategies in Tomsk, Russia. Harv Rev Psychiatry. 2012 Jan-Feb; 20(1):58-67. PMID: 22335183.
    Citations: 3     Fields:    Translation:Humans
  40. Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011 Dec; 68(12):1238-46. PMID: 22065255.
    Citations: 114     Fields:    Translation:Humans
  41. Connery HS (medical editor) . Harvard Medical School Special Health Report. Alcohol Use and Abuse. 2011. View Publication.
  42. Roger D. Weiss and Hilary Smith Connery. Integrated Group Therapy for Bipolar Disorder and Substance Abuse. 2011.
  43. Hilary Smith Connery and Shelly F. Greenfield. Alcohol Use and Abuse in Women. Encyclopedia of Lifestyle Medicine and Health. 2011.
  44. Shin SS, Mathew TA, Yanova GV, Fitzmaurice GM, Livchits V, Yanov SA, Strelis AK, Mishustin SP, Bokhan NA, Lastimoso CS, Connery HS, Hart JE, Greenfield SF. Alcohol consumption among men and women with tuberculosis in Tomsk, Russia. Cent Eur J Public Health. 2010 Sep; 18(3):132-8. PMID: 21033607.
    Citations: 9     Fields:    Translation:Humans
  45. Meade CS, Weiss RD, Fitzmaurice GM, Poole SA, Subramaniam GA, Patkar AA, Connery HS, Woody GE. HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study. J Acquir Immune Defic Syndr. 2010 Sep; 55(1):65-72. PMID: 20393347.
    Citations: 10     Fields:    Translation:Humans
  46. Mathew T, Shields A, Yanov S, Golubchikova V, Strelis A, Yanova G, Mishustin S, Fitzmaurice G, Connery H, Shin S, Greenfield SF. Performance of the alcohol use disorders identification test among tuberculosis patients in Russia. Subst Use Misuse. 2010 Mar; 45(4):598-612. PMID: 20141466.
    Citations: 8     Fields:    Translation:Humans
  47. Weiss RD, Potter JS, Provost SE, Huang Z, Jacobs P, Hasson A, Lindblad R, Connery HS, Prather K, Ling W. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology. Contemp Clin Trials. 2010 Mar; 31(2):189-99. PMID: 20116457.
    Citations: 34     Fields:    Translation:Humans
  48. Greenfield SF, Shields A, Connery HS, Livchits V, Yanov SA, Lastimoso CS, Strelis AK, Mishustin SP, Fitzmaurice G, Mathew TA, Shin S. Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation. Alcohol Clin Exp Res. 2010 Feb; 34(2):317-30. PMID: 19930235.
    Citations: 15     Fields:    Translation:Humans
  49. Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, Cook IA, Finnerty MT, Johnson BR, Nininger JE, Summergrad P, Woods SM, Yager J, Pyles R, Cross CD, Peele R, Shemo JP, Lurie L, Walker RD, Barnovitz MA, Gray SH, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C, Regier D. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2007 Apr; 164(4 Suppl):5-123. PMID: 17569411.
    Citations: 21     Fields:    Translation:Humans
  50. Trucco EM, Connery HS, Griffin ML, Greenfield SF. The relationship of self-esteem and self-efficacy to treatment outcomes of alcohol-dependent men and women. Am J Addict. 2007 Mar-Apr; 16(2):85-92. PMID: 17453609.
    Citations: 7     Fields:    Translation:Humans
  51. Kleber HD, Weiss RD, Anton RF, Rounsaville BJ, George TP, Strain EC, Greenfield SF, Ziedonis DM, Kosten TR, Hennessy G, O'Brien CP, Connery HS, McIntyre JS, Charles SC, Anzia DJ, Nininger JE, Cook IA, Summergrad P, Finnerty MT, Woods SM, Johnson BR, Yager J, Pyles R, Lurie L, Cross CD, Walker RD, Peele R, Barnovitz MA, Gray SH, Shemo JP, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C, Regier D. Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry. 2006 Aug; 163(8 Suppl):5-82. PMID: 16981488.
    Citations: 10     Fields:    Translation:Humans
  52. Connery HS, McHugh RK, Greenfield SF. Current Psychiatry. How well does AA work? That's (partly) up to you. 2005; 4(5):1-7.
  53. Connery HS, Weiss RD. Current Psychiatry. Acamprosate for discomfort of early alcohol abstinence. 2005; 4(2):90-96.
  54. O'Hare T, Sherrer MV, Connery HS, Thornton J, LaButti A, Emrick K. Further validation of the Psycho-Social Well-Being Scale (PSWS) with community clients. Community Ment Health J. 2003 Apr; 39(2):115-29. PMID: 12723846.
    Citations: 2     Fields:    Translation:Humans
  55. Connery HS. Acute symptoms and functional impairment related to September 11 terrorist attacks among rural community outpatients with severe mental illness. Harv Rev Psychiatry. 2003 Jan-Feb; 11(1):37-42. PMID: 12866740.
    Citations:    Fields:    Translation:Humans
  56. Kilts JD, Connery HS, Arrington EG, Lewis MM, Lawler CP, Oxford GS, O'Malley KL, Todd RD, Blake BL, Nichols DE, Mailman RB. Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs. J Pharmacol Exp Ther. 2002 Jun; 301(3):1179-89. PMID: 12023553.
    Citations: 30     Fields:    Translation:AnimalsCells
  57. Mottola DM, Kilts JD, Lewis MM, Connery HS, Walker QD, Jones SR, Booth RG, Hyslop DK, Piercey M, Wightman RM, Lawler CP, Nichols DE, Mailman RB. Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase. J Pharmacol Exp Ther. 2002 Jun; 301(3):1166-78. PMID: 12023552.
    Citations: 43     Fields:    Translation:AnimalsCells
  58. Smith HP, Nichols DE, Mailman RB, Lawler CP. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist. Eur J Pharmacol. 1997 Mar 26; 323(1):27-36. PMID: 9105873.
    Citations: 7     Fields:    Translation:Animals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Connery's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (216)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.